Drug
ropeginterferon alfa-2b
Marketed as BESREMI.
Generic name
ropeginterferon alfa-2b
Brand names
BESREMI
First FDA approval
2021-11-12
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761166 | BESREMI | 2021-11-12 | PHARMAESSENTIA CORP |
Manufacturers
PHARMAESSENTIA CORP
Frequently asked questions
When was ropeginterferon alfa-2b FDA approved?
Earliest FDA approval on record: 2021-11-12.
What brand names are sold as ropeginterferon alfa-2b?
BESREMI.
Sources
Appeal a ropeginterferon alfa-2b denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com